Sale!

DNM2 Gene DI-CMTB Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNM2 gene DI-CMTB genetic test is a specialized diagnostic tool designed to identify mutations in the Dynamin 2 (DNM2) gene, which are associated with a subtype of Charcot-Marie-Tooth disease known as DI-CMTB. Charcot-Marie-Tooth disease is a group of hereditary disorders that affect the peripheral nerves, leading to muscle weakness and atrophy, particularly in the extremities. The DNM2 gene plays a crucial role in endocytosis and membrane trafficking, and mutations in this gene can disrupt nerve function, contributing to the development of DI-CMTB.

This genetic test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to detect mutations with high accuracy. Undergoing this test can be crucial for individuals with a family history of Charcot-Marie-Tooth disease or those exhibiting symptoms, as it can provide a definitive diagnosis of the DI-CMTB subtype. This, in turn, can guide treatment strategies and inform patients about the progression of the disease, potential complications, and the likelihood of passing the condition on to their offspring.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNM2 Gene DI-CMTB Genetic Test

At DNA Labs UAE, we offer the DNM2 Gene DI-CMTB Genetic Test for individuals who are experiencing symptoms related to neurological disorders. This test can help diagnose conditions such as Charcot-Marie-Tooth disease type 2B1 (CMT2B1) and centronuclear myopathy (CNM), which are associated with mutations in the DNM2 gene.

Test Components

  • Price: 4400.0 AED

Sample Condition

We accept blood samples or extracted DNA for this test. Alternatively, you can provide one drop of blood on an FTA card.

Report Delivery

After the sample is received, the report will be delivered within 3 to 4 weeks.

Method

We utilize NGS technology for the DNM2 Gene DI-CMTB Genetic Test.

Test Type

This test specifically focuses on neurological disorders.

Doctor

Our team of neurologists will oversee the testing process.

Test Department

This test falls under our Genetics department.

Pre Test Information

Prior to the test, we recommend providing the clinical history of the patient who is undergoing the DNM2 Gene DI-CMTB NGS Genetic DNA Test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by DNM2 Gene DI-CMTB.

Test Details

The DNM2 gene is responsible for encoding dynamin 2, a protein involved in the process of endocytosis. Mutations in this gene have been linked to various neuromuscular disorders, including CMT2B1 and CNM.

The DI-CMTB NGS genetic testing is a type of next-generation sequencing (NGS) test specifically designed to analyze the DNM2 gene for mutations associated with CMT2B1 and CNM. This test is essential for diagnosing these disorders accurately and guiding treatment decisions. It can also provide valuable information for genetic counseling and family planning.

Test Name DNM2 Gene DI-CMTB Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DNM2 Gene DI-CMTB NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DNM2 Gene DI-CMTB
Test Details

The DNM2 gene encodes a protein called dynamin 2, which is involved in the process of endocytosis, the uptake of substances into cells. Mutations in the DNM2 gene have been associated with a range of neuromuscular disorders, including Charcot-Marie-Tooth disease type 2B1 (CMT2B1) and centronuclear myopathy (CNM).

DI-CMTB NGS genetic testing is a type of next-generation sequencing (NGS) test that analyzes the DNM2 gene for mutations associated with CMT2B1 and CNM. This test can help diagnose these disorders and guide treatment decisions. It may also be useful for genetic counseling and family planning.